Free Trial

Banque Cantonale Vaudoise Acquires 47,723 Shares of Exelon Co. (NASDAQ:EXC)

Exelon logo with Utilities background

Banque Cantonale Vaudoise lifted its stake in Exelon Co. (NASDAQ:EXC - Free Report) by 148.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,902 shares of the company's stock after purchasing an additional 47,723 shares during the quarter. Banque Cantonale Vaudoise's holdings in Exelon were worth $3,240,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Lazard Asset Management LLC increased its stake in shares of Exelon by 112.4% in the 1st quarter. Lazard Asset Management LLC now owns 31,527,396 shares of the company's stock worth $1,184,483,000 after purchasing an additional 16,686,526 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in shares of Exelon by 2.4% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 4,887,035 shares of the company's stock valued at $183,606,000 after acquiring an additional 113,428 shares during the last quarter. Los Angeles Capital Management LLC increased its position in shares of Exelon by 666.2% during the second quarter. Los Angeles Capital Management LLC now owns 3,583,477 shares of the company's stock worth $124,024,000 after acquiring an additional 3,115,763 shares during the period. Bank of Montreal Can grew its holdings in Exelon by 0.5% in the second quarter. Bank of Montreal Can now owns 3,438,056 shares of the company's stock worth $120,710,000 after purchasing an additional 15,620 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Exelon by 7.9% during the second quarter. Dimensional Fund Advisors LP now owns 3,246,500 shares of the company's stock worth $112,364,000 after purchasing an additional 237,950 shares in the last quarter. 80.92% of the stock is owned by institutional investors.

Exelon Price Performance

NASDAQ:EXC traded down $0.37 during mid-day trading on Wednesday, reaching $38.73. 5,550,962 shares of the company were exchanged, compared to its average volume of 6,750,154. The stock has a market cap of $38.92 billion, a PE ratio of 15.94, a PEG ratio of 2.79 and a beta of 0.54. The company has a quick ratio of 0.97, a current ratio of 1.09 and a debt-to-equity ratio of 1.66. Exelon Co. has a 12 month low of $33.35 and a 12 month high of $41.42. The company has a fifty day moving average of $39.68 and a 200 day moving average of $37.82.

Exelon (NASDAQ:EXC - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.67 by $0.04. Exelon had a net margin of 10.60% and a return on equity of 9.47%. The company had revenue of $6.15 billion for the quarter, compared to the consensus estimate of $5.85 billion. During the same period last year, the company earned $0.67 earnings per share. The firm's revenue was up 2.9% compared to the same quarter last year. On average, research analysts anticipate that Exelon Co. will post 2.45 EPS for the current fiscal year.

Exelon Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, November 11th will be paid a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 3.92%. The ex-dividend date is Friday, November 8th. Exelon's dividend payout ratio (DPR) is presently 62.55%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Jefferies Financial Group began coverage on shares of Exelon in a research report on Thursday, September 19th. They set a "buy" rating and a $46.00 price target on the stock. Morgan Stanley lifted their price objective on Exelon from $42.00 to $45.00 and gave the company an "equal weight" rating in a report on Wednesday, September 25th. Wells Fargo & Company boosted their price objective on Exelon from $40.00 to $42.00 and gave the company an "equal weight" rating in a research report on Friday, August 2nd. Barclays increased their target price on Exelon from $41.00 to $44.00 and gave the company an "overweight" rating in a research report on Tuesday, October 15th. Finally, UBS Group lifted their price target on Exelon from $40.00 to $43.00 and gave the stock a "neutral" rating in a report on Friday, September 20th. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $41.33.

View Our Latest Stock Analysis on Exelon

About Exelon

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Stories

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should you invest $1,000 in Exelon right now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines